CLEAN : Demonstrators protest healthcare provisions in TPP agreement

The video discusses the Trans-Pacific Partnership (TPP) and its potential negative impact on patients' access to medications. It highlights concerns about extended patent protections and intellectual property rules that could hinder the availability of affordable generic drugs. A personal testimony illustrates the high cost of medication due to lack of competition, emphasizing the life-and-death stakes for patients needing treatment.

What is the main concern discussed in the first section regarding the TPP?

• The TPP will reduce drug prices.

• The TPP will make it harder for patients to access medications.

• The TPP will have no impact on patients.

• The TPP will improve access to medications.

What do the intellectual property provisions in the TPP aim to do?

• Make medications cheaper.

• Reduce patent protections.

• Extend patent protections and protect data.

• Increase competition in the drug market.

What is the potential consequence of the TPP on patients without treatment?

• Patients will die without treatment.

• Patients will have more treatment options.

• Patients will receive free medications.

• Patients will have no change in treatment access.

Why is the drug mentioned in the final section expensive?

• It is a generic drug.

• It is a new drug.

• There is no competition.

• It is not covered by insurance.

What challenge does the TPP introduce regarding generic drugs?

• It bans generic drugs completely.

• It makes it easier to introduce generics.

• It has no effect on generics.

• It makes it harder to introduce generics.